Anchor Therapeutics, OMJPI collaborate to develop GPCR targeted therapeutics
Views 560
Tweet
Source:
www.pharmaceutical-business-review.com
Close Source
1
OptiNose enrolls first patient in Phase III intranasal technology trial
1
BioSante LibiGel study needs no modification, says DMC
1
Catalyst files US provisional patent application for GABA aminotransferase inhibitors
